Evaluate the Prognosis of MYC/TP53 Comutation in Chinese Patients with EGFR-Positive Advanced NSCLC Using Next-Generation Sequencing: A Retrospective Study

Purpose: The purpose of this study was to investigate the effect of MYC and TP53 comutations on the clinical efficacy of EGFR tyrosine kinase inhibitors (TKIs) in Chinese patients with advanced EGFR-positive nonsmall-cell lung cancer (NSCLC). Patients and methods: Tissue samples and information from...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Jin, J Gu, Juan, Liang, Yichen, Wang, Buhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Impact of Advances in Genomic Technologies in Cancer Research, Diagnostics and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761218/
https://www.ncbi.nlm.nih.gov/pubmed/36524293
http://dx.doi.org/10.1177/15330338221138213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761218/
https://www.ncbi.nlm.nih.gov/pubmed/36524293
http://dx.doi.org/10.1177/15330338221138213

Ejemplares similares